Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LIVING HUMAN-BRAIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 195 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Li, SC; Lindenberger, U; Sikstrom, S
      Aging cognition: from neuromodulation to representation

      TRENDS IN COGNITIVE SCIENCES
    2. Matthews, PM; De Stefano, N; Fazekas, F; Filippi, M; Miller, D; Seitz, RJ
      The future of magnetic resonance-based techniques in neurology

      EUROPEAN JOURNAL OF NEUROLOGY
    3. Halldin, C; Gulyas, B; Langer, O; Farde, L
      Brain radioligands - State of the art and new trends

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    4. Olsson, H; Farde, L
      Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy - A simulationstudy based on experimental data

      NEUROIMAGE
    5. Ito, H; Sudo, Y; Suhara, T; Okubo, Y; Halldin, C; Farde, L
      Error analysis for quantification of [C-11]FLB 457 binding to extrastriatal D-2 dopamine receptors in the human brain

      NEUROIMAGE
    6. Li, HF; Gildehaus, FJ; Dresel, S; Patt, JT; Shen, MH; Zhu, T; Liu, B; Tang, ZG; Tatsch, K; Hahn, K
      Comparison of in vivo dopamine D2 receptor binding of [I-123]AIBZM and [I-123]IBZM in rat brain

      NUCLEAR MEDICINE AND BIOLOGY
    7. Kestler, LP; Walker, E; Vega, EM
      Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings

      BEHAVIOURAL PHARMACOLOGY
    8. Cumming, P; Munk, OL; Doudet, D
      Loss of metabolites from monkey striatum during PET with FDOPA

      SYNAPSE
    9. Danielsen, EH; Smith, D; Hermansen, F; Gjedde, A; Cumming, P
      Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo

      SYNAPSE
    10. Price, JC; Lopresti, BJ; Meltzer, CC; Smith, GS; Mason, NS; Huang, Y; Holt, DP; Gunn, RN; Mathis, CA
      Analyses of [F-18]altanserin bolus injection PET data. II: Consideration of radiolabeled metabolites in humans

      SYNAPSE
    11. Bubser, M; Backstrom, JR; Sanders-Bush, E; Roth, BL; Deutch, AY
      Distribution of serotonin 5-HT2A receptors in afferents of the rat striatum

      SYNAPSE
    12. Fischman, AJ; Bonab, AA; Babich, JW; Livni, E; Alpert, NM; Meltzer, PC; Madras, BK
      [C-11,I-127] altropane: A highly selective ligand for PET imaging of dopamine transporter sites

      SYNAPSE
    13. Carrey, N
      Developmental neurobiology: Implications for pediatric psychopharmacology

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    14. Koeppe, RA; Raffel, DM; Snyder, SE; Ficaro, EP; Kilbourn, MR; Kuhl, DE
      Dual-[C-11]tracer single-acquisition positron emission tomography studies

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    15. Danielsen, EH; Smith, DF; Andersen, F; Gee, AD; Bender, D; Hansen, SB; Hermansen, F; Ostergaard, L; Cumming, P; Gjedde, A
      FDOPA metabolism in the adult porcine brain: influence of tracer circulation time and VOI selection on estimates of striatal DOPA decarboxylation

      JOURNAL OF NEUROSCIENCE METHODS
    16. Kapur, S
      Neuroimaging and drug development: An algorithm for decision making

      JOURNAL OF CLINICAL PHARMACOLOGY
    17. Mazziotta, JC
      Brain mapping: its use in patients with neurological disorders

      REVUE NEUROLOGIQUE
    18. Herzog, H
      In vivo functional imaging with SPECT and PET

      RADIOCHIMICA ACTA
    19. Inoue, M; Suhara, T; Sudo, Y; Okubo, Y; Yasuno, F; Kishimoto, T; Yoshikawa, K; Tanada, S
      Age-related reduction of extrastriatal dopamine D-2 receptor measured by PET

      LIFE SCIENCES
    20. Smith, YR; Zubieta, JK
      Neuroimaging of aging and estrogen effects on central nervous system physiology

      FERTILITY AND STERILITY
    21. Meltzer, CC; Drevets, WC; Price, JC; Mathis, CA; Lopresti, B; Greer, PJ; Villemagne, VL; Holt, D; Mason, NS; Houck, PR; Reynolds, CF; DeKosky, ST
      Gender-specific aging effects on the serotonin 1A receptor

      BRAIN RESEARCH
    22. Miller, DD; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD
      Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

      BIOLOGICAL PSYCHIATRY
    23. Farde, L; Ginovart, N; Halldin, C; Chou, YH; Olsson, H; Swahn, CG
      A PET study of [C-11]beta-CIT-FE binding to the dopamine transporter in the monkey and human brain

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    24. van Waarde, A
      Measuring receptor occupancy with PET

      CURRENT PHARMACEUTICAL DESIGN
    25. Laakso, A; Hietala, J
      PET studies of brain monoamine transporters

      CURRENT PHARMACEUTICAL DESIGN
    26. Gibson, RE; Burns, HD; Hamill, TG; Eng, WS; Francis, BE; Ryan, C
      Non-invasive radiotracer imaging as a tool for drug development

      CURRENT PHARMACEUTICAL DESIGN
    27. Laruelle, M
      The role of model-based methods in the development of single scan techniques

      NUCLEAR MEDICINE AND BIOLOGY
    28. Carson, RE
      PET physiological measurements using constant infusion

      NUCLEAR MEDICINE AND BIOLOGY
    29. Logan, J
      Graphical analysis of PET data applied to reversible and irreversible tracers

      NUCLEAR MEDICINE AND BIOLOGY
    30. Danielsen, EH; Cumming, P; Andersen, F; Bender, D; Brevig, T; Falborg, L; Gee, A; Gillings, NM; Hansen, SB; Hermansen, F; Johansen, J; Johansen, TE; Dahl-Jorgensen, A; Jorgensen, HA; Meyer, M; Munk, O; Pedersen, EB; Poulsen, PH; Rodell, AB; Sakoh, M; Simonsen, CZ; Smith, DF; Sorensen, JC; Ostergard, L; Zimmer, J; Gjedde, A; Moller, A
      The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted toa minipig model of Parkinson's disease: Preliminary findings of effect of MPTP poisoning on striatal dopaminergic markers

      CELL TRANSPLANTATION
    31. Ishizu, K; Smith, DF; Bender, D; Danielsen, E; Hansen, SB; Wong, DF; Cumming, P; Gjedde, A
      Positron emission tomography of radioligand binding in porcine striatum invivo: Haloperidol inhibition linked to endogenous ligand release

      SYNAPSE
    32. Rousset, OG; Deep, P; Kuwabara, H; Evans, AC; Gjedde, AH; Cumming, P
      Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[F-18]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects

      SYNAPSE
    33. Pinborg, LH; Videbaek, C; Knudsen, GM; Swahn, CG; Halldin, C; Friberg, L; Paulson, OB; Lassen, NA
      Dopamine D-2 receptor quantification in extrastriatal brain regions using [I-123]epidepride with bolus/infusion

      SYNAPSE
    34. Patat, A
      Clinical pharmacology of psychotropic drugs

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    35. Kaasinen, V; Vilkman, H; Hietala, J; Nagren, K; Helenius, H; Olsson, H; Farde, L; Rinne, JO
      Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain

      NEUROBIOLOGY OF AGING
    36. Matochik, JA; Chefer, SI; Lane, MA; Woolf, RI; Morris, ED; Ingram, DK; Roth, GS; London, ED
      Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging

      NEUROBIOLOGY OF AGING
    37. van Dyck, CH; Tan, PZ; Baldwin, RM; Amici, LA; Garg, PK; Ng, CK; Soufer, R; Charney, DS; Innis, RB
      PET quantification of 5-HT2A receptors in the human brain: A constant infusion paradigm with [F-18]altanserin

      JOURNAL OF NUCLEAR MEDICINE
    38. Okubo, Y; Suhara, T; Suzuki, K; Kobayashi, K; Inoue, O; Terasaki, O; Someya, Y; Sassa, T; Sudo, Y; Matsushima, E; Iyo, M; Tateno, Y; Toru, M
      Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography

      LIFE SCIENCES
    39. Yee, RE; Huang, SC; Stout, DB; Irwin, I; Shoghi-Jadid, K; Togaski, DM; DeLanney, LE; Langston, JW; Satyamurthy, N; Farahani, KF; Phelps, ME; Barrio, JR
      Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity inMPTP-treated squirrel monkeys: In vivo and in vitro investigations

      JOURNAL OF NEUROCHEMISTRY
    40. Yatham, LN; Liddle, PF; Shiah, IS; Scarrow, G; Lam, RW; Adam, MJ; Zis, AP; Ruth, TJ
      Brain serotonin(2) receptors in major depression - A positron emission tomography study

      ARCHIVES OF GENERAL PSYCHIATRY
    41. Bigliani, V; Mulligan, RS; Acton, PD; Ohlsen, RI; Pike, VW; Ell, PJ; Gacinovic, S; Kerwin, RW; Pilowsky, LS
      Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [I-123]epidepride single photon emission tomography (SPET) study

      PSYCHOPHARMACOLOGY
    42. Jonsson, EG; Nothen, MM; Grunhage, F; Farde, L; Nakashima, Y; Propping, P; Sedvall, GC
      Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers

      MOLECULAR PSYCHIATRY
    43. Perlmutter, JS; Moerlein, SM
      PET measurements of dopaminergic pathways in the brain

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    44. Ito, H; Okubo, Y; Halldin, C; Farde, L
      Mapping of central D-2 dopamine receptors in man using [C-11]raclopride: PET with anatomic standardization technique

      NEUROIMAGE
    45. Brust, P; Bauer, R; Vorwieger, G; Walter, B; Bergmann, R; Fuchtner, F; Steinbach, J; Zwiener, U; Johannsen, B
      Upregulation of the aromatic amino acid decarboxylase under neonatal asphyxia

      NEUROBIOLOGY OF DISEASE
    46. Ahlert, G
      Biogerontology: Present state and recent developments

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    47. Inoue, O; Kobayashi, K; Gee, A
      Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments

      CRITICAL REVIEWS IN NEUROBIOLOGY
    48. Meltzer, CC
      Neuropharmacology and receptor studies in the elderly

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    49. Cumming, P; Yokoi, F; Chen, AJ; Deep, P; Dagher, A; Reutens, D; Kapczinski, F; Wong, DF; Gjedde, A
      Pharmacokinetics of radiotracers in human plasma during positron emission tomography

      SYNAPSE
    50. Danielsen, EH; Smith, DF; Gee, AD; Venkatachalam, TK; Hansen, SB; Hermansen, F; Gjedde, A; Cumming, P
      Cerebral 6-[F-18]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography

      SYNAPSE
    51. Ito, Y; Fujita, M; Shimada, S; Watanabe, Y; Okada, T; Kusuoka, H; Tohyama, M; Nishimura, T
      Comparison between the decrease of dopamine transporter and that of L-DOPAuptake for detection of early to advanced stage of Parkinson's disease in animal models

      SYNAPSE
    52. Booij, J; Tissingh, G; Winogrodzka, A; van Royen, EA
      Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    53. Kuikka, JT; Tupala, E; Bergstrom, KA; Hiltunen, J; Tiihonen, J
      Iodine-123 labelled PE21 for dopamine transporter imaging: influence of age in healthy subjects

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    54. Fujita, H; Kuwabara, H; Reutens, DC; Gjedde, A
      Oxygen consumption of cerebral cortex fails to increase during continued vibrotactile stimulation

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    55. Morris, ED; Chefer, SI; Lane, MA; Muzic, RF; Wong, DF; Dannals, RF; Matochik, JA; Bonab, AA; Villemagne, VL; Grant, SJ; Ingram, DK; Roth, GS; London, ED
      Loss of D-2 receptor binding with age in rhesus monkeys: Importance of correction for differences in striatal size

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    56. Koeppe, RA; Frey, KA; Kuhl, DE; Kilbourn, MR
      Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [C-11]dihydrotetrabenazine

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    57. Olsson, H; Halldin, C; Swahn, CG; Farde, L
      Quantification of [C-11]FLB 457 binding to extrastriatal dopamine receptors in the human brain

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    58. Tsukada, H
      Delivery of radioligands for positron emission tomography (PET) in the central nervous system

      ADVANCED DRUG DELIVERY REVIEWS
    59. Abbott, NJ; Chugani, DC; Zaharchuk, G; Rosen, BR; Lo, EH
      Delivery of imaging agents into brain

      ADVANCED DRUG DELIVERY REVIEWS
    60. Nobler, MS; Mann, JJ; Sackeim, HA
      Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging

      BRAIN RESEARCH REVIEWS
    61. Booij, J; Hemelaar, JTGM; Speelman, JD; de Bruin, K; Janssen, AGM; van Royen, EA
      One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [I-123]FPCIT SPECT

      JOURNAL OF NUCLEAR MEDICINE
    62. Wahl, LM; Asselin, MC; Nahmias, C
      Regions of interest in the venous sinuses as input functions for quantitative PET

      JOURNAL OF NUCLEAR MEDICINE
    63. Bigliani, V; Pilowsky, LS
      In vivo neuropharmacology of schizophrenia

      BRITISH JOURNAL OF PSYCHIATRY
    64. Soares, JC; Innis, RB
      Neurochemical brain imaging investigations of schizophrenia

      BIOLOGICAL PSYCHIATRY
    65. Seeman, P; Tallerico, T
      Rapid release of antipsychotic drugs from dopamine D-2 receptors: An explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine

      AMERICAN JOURNAL OF PSYCHIATRY
    66. Lewis, R; Kapur, S; Jones, C; DaSilva, J; Brown, GM; Wilson, AA; Houle, S; Zipursky, RB
      Serotonin 5-HT2 receptors in schizophrenia: A PET study using [F-18]setoperone in neuroleptic-naive patients and normal subjects

      AMERICAN JOURNAL OF PSYCHIATRY
    67. Borbely, K; Brooks, RA; Wong, DF; Burns, RS; Cumming, P; Gjedde, A; Di Chiro, G
      NMSP binding to dopamine and serotonin receptors in MPTP-induced parkinsonism: relation to dopa therapy

      ACTA NEUROLOGICA SCANDINAVICA
    68. Kanerva, H; Vilkman, H; Nagren, K; Kilkku, O; Kuoppamaki, M; Syvalahti, E; Hietala, J
      Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study

      PSYCHOPHARMACOLOGY
    69. OBIOLS JE; CARULLA M
      BIOLOGICAL BASIS OF SCHIZOPHRENIA - NEURO CHEMICAL AND NEUROANATOMICAL ASPECTS

      Psicologia conductual
    70. Bergstrom, KA
      Radiopharmaceuticals for the dopamine transporter in brain

      RADIOCHEMISTRY
    71. BOTTONCETTI A; PUPI A; SESTINI S; PECORALE A; RASPANTI S; MELDOLESI U
      FIRST-PASS CEREBRAL EXTRACTION OF BENZAMIDE-DERIVATIVE RADIOTRACERS FOR SPECT

      Nuclear medicine and biology
    72. MELTZER CC; SMITH G; DEKOSKY ST; POLLOCK BG; MATHIS CA; MOORE RY; KUPFER DJ; REYNOLDS CF
      SEROTONIN IN AGING, LATE-LIFE DEPRESSION, AND ALZHEIMERS-DISEASE - THE EMERGING ROLE OF FUNCTIONAL IMAGING

      Neuropsychopharmacology
    73. LEGER G; GJEDDE A; KUWABARA H; GUTTMAN M; CUMMING P
      EFFECT OF CATECHOL-O-METHYLTRANSFERASE INHIBITION ON BRAIN UPTAKE OF [F-18] FLUORODOPA - IMPLICATIONS FOR COMPARTMENTAL MODELING AND CLINICAL USEFULNESS

      Synapse
    74. LEVER JR; ILGIN N; MUSACHIO JL; SCHEFFEL U; FINLEY PA; FLESHER JE; NATARAJAN TK; WAGNER HN; FROST JJ
      AUTORADIOGRAPHIC AND SPECT IMAGING OF CEREBRAL OPIOID RECEPTORS WITH AN I-123 LABELED ANALOG OF DIPRENORPHINE

      Synapse
    75. BRUST P; BAUER R; WALTER B; BERGMANN R; FUCHTNER F; VORWIEGER G; STEINBACH J; JOHANNSEN B; ZWIENER U
      SIMULTANEOUS MEASUREMENT OF [F-18] FDOPA METABOLISM AND CEREBRAL BLOOD-FLOW IN NEWBORN PIGLETS

      International journal of developmental neuroscience
    76. LEWIS R
      TYPICAL AND ATYPICAL ANTIPSYCHOTICS IN ADOLESCENT SCHIZOPHRENIA - EFFICACY, TOLERABILITY, AND DIFFERENTIAL SENSITIVITY TO EXTRAPYRAMIDAL SYMPTOMS

      Canadian journal of psychiatry
    77. HILTUNEN J; AKERMAN KK; KUIKKA JT; BERGSTROM KA; HALLDIN C; NIKULA T; RASANEN P; TIIHONEN J; VAUHKONEN M; KARHU J; KUPILA J; LANSIMIES E; FARDE L
      I-123 LABELED NOR-BETA-CIT AS A POTENTIAL TRACER FOR SEROTONIN TRANSPORTER IMAGING IN THE HUMAN BRAIN WITH SINGLE-PHOTON EMISSION TOMOGRAPHY

      European journal of nuclear medicine
    78. DRESEL SHJ; KUNG MP; PLOSSL K; MEEGALLA SK; KUNG HF
      PHARMACOLOGICAL EFFECTS OF DOPAMINERGIC DRUGS ON IN-VIVO BINDING OF [TC-99M]TRODAT-1 TO THE CENTRAL DOPAMINE TRANSPORTERS IN RATS

      European journal of nuclear medicine
    79. ITO H; HIETALA J; BLOMQVIST G; HALLDIN C; FARDE L
      COMPARISON OF THE TRANSIENT EQUILIBRIUM AND CONTINUOUS-INFUSION METHOD FOR QUANTITATIVE PET ANALYSIS OF [C-11] RACLOPRIDE BINDING

      Journal of cerebral blood flow and metabolism
    80. ANDREE B; NYBERG S; ITO H; GINOVART N; BRUNNER F; JAQUET F; HALLDIN C; FARDE L
      POSITRON EMISSION TOMOGRAPHIC ANALYSIS OF DOSE-DEPENDENT MDL-100,907 BINDING TO 5-HYDROXYTRYPTAMINE-2A RECEPTORS IN THE HUMAN BRAIN

      Journal of clinical psychopharmacology
    81. NYBERG S; NILSSON U; OKUBO Y; HALLDIN C; FARDE L
      IMPLICATIONS OF BRAIN IMAGING FOR THE MANAGEMENT OF SCHIZOPHRENIA

      International clinical psychopharmacology
    82. ICHISE M; BALLINGER JR; TANAKA F; MOSCOVITCH M; STGEORGEHYSLOP PH; RAPHAEL D; FREEDMAN M
      AGE-RELATED-CHANGES IN D-2 RECEPTOR-BINDING WITH IODINE-123-IODOBENZOFURAN SPECT

      The Journal of nuclear medicine
    83. OUCHI Y; TSUKADA H; KAKIUCHI T; NISHIYAMA S; FUTATSUBASHI M
      CHANGES IN CEREBRAL BLOOD-FLOW AND POSTSYNAPTIC MUSCARINIC CHOLINERGIC ACTIVITY IN RATS WITH BILATERAL CAROTID-ARTERY LIGATION

      The Journal of nuclear medicine
    84. ITO H; NYBERG S; HALLDIN C; LUNDKVIST C; FARDE L
      PET IMAGING OF CENTRAL 5-HT2A RECEPTORS WITH CARBON-11-MDL-100,907

      The Journal of nuclear medicine
    85. SUDO Y; SUHARA T; HONDA Y; NAKAJIMA T; OKUBO Y; SUZUKI K; NAKASHIMA Y; YOSHIKAWA K; OKAUCHI T; SASAKI Y; MATSUSHITA M
      MUSCARINIC CHOLINERGIC RECEPTORS IN HUMAN NARCOLEPSY - A PET STUDY

      Neurology
    86. Meltzer, CC; Smith, G; Price, JC; Reynolds, CF; Mathis, CA; Greer, P; Lopresti, B; Mintun, MA; Pollock, BG; Ben-Eliezer, D; Cantwell, MN; Kaye, W; DeKosky, ST
      Reduced binding of [F-18]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction

      BRAIN RESEARCH
    87. STALEY JK; MALISON RT; INNIS RB
      IMAGING OF THE SEROTONERGIC SYSTEM - INTERACTIONS OF NEUROANATOMICAL AND FUNCTIONAL ABNORMALITIES OF DEPRESSION

      Biological psychiatry
    88. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI E; HIETALA J
      SEX-DIFFERENCES IN THE STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN-VIVO

      The American journal of psychiatry
    89. VAFAEE MS; MARRETT S; MEYER E; EVANS AC; GJEDDE A
      INCREASED OXYGEN-CONSUMPTION IN HUMAN VISUAL-CORTEX - RESPONSE TO VISUAL-STIMULATION

      Acta neurologica Scandinavica
    90. LARISCH R; KLIMKE A
      ON THE CLINICAL IMPACT OF CEREBRAL DOPAMINE D-2 RECEPTOR SCINTIGRAPHY

      Nuklearmedizin
    91. MEGURO K; ITOH M; YANAI K; TAKASE K; YAMAGUCHI S; IDO T; YAMADORI A
      PSYCHIATRIC WANDERING BEHAVIOR IN DEMENTIA PATIENTS CORRELATED WITH INCREASED STRIATAL DOPAMINE D-2 RECEPTOR AS SHOWN BY [C-11] YM-09151-2 AND POSITRON EMISSION TOMOGRAPHY

      European journal of neurology
    92. SAMNICK S; BRANDAU W; NOLKEN G; GERHARDS HJ; SCHOBER O
      PREPARATION OF 123]IODOBENZOYL)-1,3,8-TRIAZASPIRO[4,5]DECAN-4-ONE - ANOVEL SELECTIVE SEROTONIN 5-HT2 RECEPTOR AGENT

      Nuclear medicine and biology
    93. FARDE L
      BRAIN IMAGING OF SCHIZOPHRENIA - THE DOPAMINE HYPOTHESIS

      Schizophrenia research
    94. KEGELES LS; MANN JJ
      IN-VIVO IMAGING OF NEUROTRANSMITTER SYSTEMS USING RADIOLABELED RECEPTOR LIGANDS

      Neuropsychopharmacology
    95. GRUNDER G; YOKOI F; OFFORD SJ; RAVERT HT; DANNALS RF; SALZMANN JK; SZYMANSKI S; WILSON PD; HOWARD DR; WONG DF
      TIME-COURSE OF 5-HT2A RECEPTOR OCCUPANCY IN THE HUMAN BRAIN AFTER A SINGLE ORAL DOSE OF THE PUTATIVE ANTIPSYCHOTIC DRUG MDL-100,907 MEASURED BY POSITRON EMISSION TOMOGRAPHY

      Neuropsychopharmacology
    96. VOLLENWEIDER FX; LEENDERS KL; SCHARFETTER C; MAGUIRE P; STADELMANN O; ANGST J
      POSITRON EMISSION TOMOGRAPHY AND FLUORODEOXYGLUCOSE STUDIES OF METABOLIC HYPERFRONTALITY AND PSYCHOPATHOLOGY IN THE PSILOCYBIN MODEL OF PSYCHOSIS

      Neuropsychopharmacology
    97. WONG DF
      ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS - COMMENTARY

      Neuropsychopharmacology
    98. RUOTTINEN HM; RINNE JO; OIKONEN VJ; BERGMAN JR; HAAPARANTA MT; SOLIN OH; RUOTSALAINEN UH; RINNE UK
      STRIATAL B-[F-18]FLUORODOPA ACCUMULATION AFTER COMBINED INHIBITION OFPERIPHERAL CATECHOL-O-METHYLTRANSFERASE AND MONOAMINE-OXIDASE TYPE-B - DIFFERING RESPONSE IN RELATION TO PRESYNAPTIC DOPAMINERGIC DYSFUNCTION

      Synapse
    99. KASSIOU M; RAVERT HT; MATHEWS WB; MUSACHIO JL; LONDON ED; DANNALS RF
      SYNTHESIS OF (1-[C-11]METHYL-2(S)-PYRROLIDINYL)METHOXY]PYRIDINE AND (1-[C-11]METHYL-2(R)-PYRROLIDINYL)METHOXY]PYRIDINE - RADIOLIGANDS FOR IN-VIVO STUDIES OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS

      Journal of labelled compounds & radiopharmaceuticals
    100. FISCHMAN AJ; ALPERT NM; BABICH JW; RUBIN RH
      THE ROLE OF POSITRON-EMISSION-TOMOGRAPHY IN PHARMACOKINETIC ANALYSIS

      Drug metabolism reviews


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:28:29